Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 Polymorphism

NCT00915733 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Myocardial Infarction

Interventions

DRUG: cilostazol
DRUG: clopidogrel (Plavix)
GENETIC: CYP2C19
DRUG: aspirin (Acetylsalicylic acid)

Sponsor

Gyeongsang National University Hospital